From Bedside to Bench: Methods in Precision Medicine

Precision medicine is a novel approach to clinical practice aimed at integrating traditional clinical data with biomarkers, which are able to further characterize patients, thus maximizing health outcomes in particular cases. Biomarker research is based on robust and rigorous laboratorial methodologies aimed at studying specific tissues, cells, or molecules. In this chapter, we provide a succinct overview of the various techniques available in histology and cell and molecular biology with a ubiquitous use in clinical medicine. We also give a few examples of known biomarkers in stroke and the techniques used for their discovery and identification/quantification.

[1]  C. Ponting,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[2]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[3]  Roman Kaliszan,et al.  Metabolomics for laboratory diagnostics. , 2015, Journal of pharmaceutical and biomedical analysis.

[4]  Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review , 2019, Cerebrovascular Diseases.

[5]  N. Samani,et al.  The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of HDAC9 via E2F3 and Rb1. , 2019, Stroke.

[6]  S. Qanbari,et al.  A handmade DNA extraction kit using laundry powder; insights on simplicity, cost-efficiency, rapidity, safety and the quality of purified DNA , 2019, Animal biotechnology.

[7]  J. L. Sánchez-Trincado,et al.  Fundamentals and Methods for T- and B-Cell Epitope Prediction , 2017, Journal of immunology research.

[8]  H. Swerdlow,et al.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.

[9]  T. Lehtimäki,et al.  Evidence HDAC9 Genetic Variant Associated With Ischemic Stroke Increases Risk via Promoting Carotid Atherosclerosis , 2013, Stroke.

[10]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.

[11]  M. Ratajczak,et al.  Analytical capabilities of the ImageStream cytometer. , 2011, Methods in cell biology.

[12]  D. S. Hage Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications. , 2017, Clinical chemistry.

[13]  R. Green,et al.  Northern blotting. , 2013, Methods in enzymology.

[14]  Luis Cano,et al.  Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study , 2017, Stroke.

[15]  I. Shaifali,et al.  Antibiotic Susceptibility Patterns of Urinary Pathogens in Female Outpatients , 2012, North American journal of medical sciences.

[16]  Immunogenicity of infectious pathogens and vaccine antigens , 2015, BMC Immunology.

[17]  Jinkwon Kim,et al.  Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. , 2012, Atherosclerosis.

[18]  Roger E Bumgarner Overview of DNA microarrays: types, applications, and their future. , 2013, Current protocols in molecular biology.

[19]  J. Attia,et al.  Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis , 2018, BioMed research international.

[20]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) , 2019, European journal of immunology.

[21]  R. Durbin,et al.  Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly , 2016, bioRxiv.

[22]  K. Furie,et al.  Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke , 2012, Stroke.

[23]  M. Mann,et al.  Decoding signalling networks by mass spectrometry-based proteomics , 2010, Nature Reviews Molecular Cell Biology.

[24]  Evan E Eichler,et al.  Genetic Variation, Comparative Genomics, and the Diagnosis of Disease. , 2019, The New England journal of medicine.

[25]  D. Lauffenburger,et al.  Systems Analysis of EGF Receptor Signaling Dynamics with Micro-Western Arrays , 2010, Nature Methods.

[26]  Yuanfei Deng,et al.  Identification of novel biomarkers in ischemic stroke: a genome-wide integrated analysis , 2020, BMC Medical Genetics.

[27]  J. Pitt,et al.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. , 2009, The Clinical biochemist. Reviews.

[28]  Chunbing Zhang,et al.  Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Ischemic Stroke , 2014, Cellular and Molecular Neurobiology.

[29]  M. Metzker Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[30]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[31]  F. Sharp,et al.  HDAC9 Polymorphism Alters Blood Gene Expression in Patients with Large Vessel Atherosclerotic Stroke , 2018, Translational Stroke Research.

[32]  Suleyman Aydin,et al.  A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA , 2015, Peptides.

[33]  Karsten König,et al.  In vivo multiphoton NADH fluorescence reveals depth-dependent keratinocyte metabolism in human skin. , 2013, Biophysical journal.

[34]  B. Cho,et al.  Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults , 2017, PloS one.

[35]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[36]  S. Nishizuka,et al.  Reverse-phase protein lysate microarrays for cell signaling analysis , 2008, Nature Protocols.

[37]  H. ten Cate,et al.  Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[38]  C. Price,et al.  A Systematic Review and Meta-Analysis of Molecular Biomarkers Associated with Early Neurological Deterioration Following Acute Stroke , 2018, Cerebrovascular Diseases.

[39]  M. Christ-Crain,et al.  BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events , 2014, PloS one.

[40]  F. Sharp,et al.  Biomarker Panels in Ischemic Stroke , 2015, Stroke.

[41]  Robert M Califf,et al.  Biomarker definitions and their applications , 2018, Experimental biology and medicine.

[42]  Myron K. Brakke,et al.  Density Gradient Centrifugation: A New Separation Technique1 , 1951 .

[43]  G. Nolan,et al.  Mass Cytometry: Single Cells, Many Features , 2016, Cell.

[44]  D. S. Hage,et al.  High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents. , 2018, The Analyst.

[45]  L. Krishnan,et al.  Introduction to the immune system. , 2013, Methods in molecular biology.

[46]  A. Maisel,et al.  Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides. , 2018, Heart failure clinics.

[47]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[48]  Michael Forsting,et al.  European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage , 2013, Cerebrovascular Diseases.

[49]  S. Hell,et al.  Fluorescence nanoscopy in cell biology , 2017, Nature Reviews Molecular Cell Biology.

[50]  J. Lee,et al.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.

[51]  Ping-Chang Yang,et al.  Western Blot: Technique, Theory, and Trouble Shooting , 2012, North American journal of medical sciences.

[52]  Devon S Chabot-Richards,et al.  White blood cell counts: reference methodology. , 2015, Clinics in laboratory medicine.

[53]  P. Zheng,et al.  Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke , 2016, Journal of Neuroinflammation.

[54]  Shaghayegh Haghjooy Javanmard,et al.  Comparison of SYBR Green and TaqMan methods in quantitative real-time polymerase chain reaction analysis of four adenosine receptor subtypes , 2014, Advanced biomedical research.

[55]  Russell J. Dickson,et al.  Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials , 2019, Front. Oncol..

[56]  S. Taylor-Robinson,et al.  Mass Spectrometry: A Guide for the Clinician. , 2019, Journal of clinical and experimental hepatology.

[57]  Yanjun Zeng,et al.  Circulating microRNAs as novel potential biomarkers for early diagnosis of acute stroke in humans. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[58]  D. Matulis Selective Precipitation of Proteins , 1997, Current protocols in protein science.

[59]  J. Maguire NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium (ISGC)., Attia, J. R., & Holliday, E. (2015) Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study. Lancet Neurology, 174-184. doi:10.1016/S1474-4422(15)00338-5 , 2016 .

[60]  Christopher G Chute,et al.  Classification, Ontology, and Precision Medicine. , 2018, The New England journal of medicine.

[61]  Hiroshi Sato,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.

[62]  T. Sobrino,et al.  High Serum Levels of Pro-Brain Natriuretic Peptide (pro BNP) Identify Cardioembolic Origin in Undetermined Stroke , 2009, Disease markers.

[63]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[64]  D. Barros-Silva,et al.  Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications , 2018, Genes.

[65]  Chunbing Zhang,et al.  An Antagomir to MicroRNA-106b-5p Ameliorates Cerebral Ischemia and Reperfusion Injury in Rats Via Inhibiting Apoptosis and Oxidative Stress , 2016, Molecular Neurobiology.

[66]  D. Leys,et al.  Biological and imaging predictors of cognitive impairment after stroke: a systematic review , 2018, Journal of Neurology.

[67]  Yuxing Feng,et al.  Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis , 2018, The International journal of neuroscience.

[68]  C. Sudlow,et al.  Low-frequency and common genetic variation in ischemic stroke , 2016, Neurology.

[69]  Nathan Cermak,et al.  Intracellular Water Exchange for Measuring the Dry Mass, Water Mass and Changes in Chemical Composition of Living Cells , 2013, PloS one.

[70]  Francesca Giordano,et al.  Oxford Nanopore MinION Sequencing and Genome Assembly , 2016, Genom. Proteom. Bioinform..

[71]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[72]  J. Montaner,et al.  B-type natriuretic peptides and mortality after stroke , 2013, Neurology.

[73]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[74]  Carlos González,et al.  Heterochromatin protein 1α interacts with parallel RNA and DNA G-quadruplexes , 2019, Nucleic acids research.

[75]  S. Misra,et al.  Blood‐based protein biomarkers for stroke differentiation: A systematic review , 2017, Proteomics. Clinical applications.

[76]  Thomas Shafee,et al.  Transcriptomics technologies , 2017, PLoS Comput. Biol..

[77]  H Pertoft,et al.  Fractionation of cells and subcellular particles with Percoll. , 2000, Journal of biochemical and biophysical methods.

[78]  Keith W. Muir,et al.  Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage? , 2019, Stroke.

[79]  Ana Catarina Fonseca,et al.  European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke , 2018, European journal of neurology.

[80]  †The International HapMap Consortium The International HapMap Project , 2003, Nature.

[81]  C. Sudlow,et al.  Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.

[82]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[83]  G. Rennert,et al.  Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study , 2015, Journal of thrombosis and haemostasis : JTH.

[84]  Christine M Eng,et al.  Next-Generation Sequencing to Diagnose Suspected Genetic Disorders. , 2018, The New England journal of medicine.

[85]  G. Büyükköroğlu,et al.  Techniques for Protein Analysis , 2018 .

[86]  S. Peirson,et al.  RNA extraction from mammalian tissues. , 2007, Methods in molecular biology.

[87]  Thomas Züllig,et al.  Lipidomics from sample preparation to data analysis: a primer , 2019, Analytical and Bioanalytical Chemistry.

[88]  M. Mazighi,et al.  European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke , 2019, Journal of NeuroInterventional Surgery.